microRNA-10b is a prognostic biomarker for melanoma

Modern Pathology

Volumn 29, Issue 2, 2016, Pages 112-121

  Saldanha, Gerald ^a,b   Elshaw, Shona ^a   Sachs, Parysatis ^a   Alharbi, Hisham ^a   Shah, Prashant ^a   Jothi, Ann ^a   Pringle, J Howard ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 10B; MICRORNA 200B; MICRORNA; MIRN10 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CANCER STAGING; GENETIC ASSOCIATION STUDY; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; SECONDARY; SKIN TUMOR; STATISTICAL MODEL; VALIDATION STUDY;

AGED; BIOMARKERS, TUMOR; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 84956673019     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2015.149     Document Type: Article

References (43)

1. Bartel DP. microRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
2. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-15529.
3. Fabbri M. microRNAs and cancer: towards a personalized medicine. Curr Mol Med 2013;13:751-756.
4. Glud M, Klausen M, Gniadecki R et al. microRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. J Invest Dermatol 2008;1219-1224.
5. Zhang L, Huang J, Yang N et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006;103:9136-9141.
6. Gaur A, Jewell DA, Liang Y et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007;67:2456-2468.
7. Caramuta S, Egyhazi S, Rodolfo M et al. microRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010;130:2062-2070.
8. Satzger I, Mattern A, Kuettler U et al. microRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer 2010;126:2553-2562.
9. Segura MF, Belitskaya-Levy I, Rose AE et al. Melanoma microRNA signature predicts post-recurrence survival. Clin Cancer Res 2010;16:1577-1586.
10. Jayawardana K, Schramm SJ, Tembe V et al. Identification, review and systematic cross-validation of microrna prognostic signatures in metastatic melanoma. J Invest Dermatol 2015; doi:10.1038/jid.2015.355 (e-pub ahead of print).
11. Tembe V, Schramm SJ, Stark MS et al. microRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. Pigment Cell Melanoma Res 2015;28:254-266.
12. Hanniford D, Zhong J, Koetz L et al. A miRNA-based signature detected in primary melanoma tissue predicts development of brain metastasis. Clin Cancer Res 2015;21:4903-4912.
13. Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 2014;13:622-638.
14. Saldanha G, Potter L, Shendge P et al. Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma. J Invest Dermatol 2013;133:1381-1384.
15. Grignol V, Fairchild ET, Zimmerer JM et al. miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. Br J Cancer 2011;105:1023-1029.
16. Jiang L, Lv X, Li J et al. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma. Acta Histochem 2011;114:582-588.
17. Yang CH, Yue J, Pfeffer SR et al. microRNA-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 2011;286: 39172-39178.
18. Satzger I, Mattern A, Kuettler U et al. microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells. Exp Dermatol 2012;21:509-514.
19. Martin Del Campo SE, Latchana N, Levine KM et al. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor. PLoS One 2015;10:e0115919.
20. Caramel J, Papadogeorgakis E, Hill L et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 2013;24:466-480.
21. Dar AA, Majid S, de Semir D et al. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem 2011;286:16606-16614.
22. Elson-Schwab I, Lorentzen A, Marshall CJ. microRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 2010;5:e13176.
23. Hanna JA, Hahn L, Agarwal S et al. In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Lab Invest 2012;92:1390-1397.
24. Liu S, Tetzlaff MT, Liu A et al. Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 2012;92:1084-1096.
25. van Kempen LC, van den Hurk K, Lazar V et al. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. Virchows Arch 2012;461:441-448.
26. Xu Y, Brenn T, Brown ER et al. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer 2012;106:553-561.
27. Mestdagh P, Van Vlierberghe P, De Weer A et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64.
28. Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:e179.
29. Vandesompele J, De Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:1-11.
30. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245-5250.
31. Jorgensen S, Baker A, Moller S et al. Robust one-day in situ hybridization protocol for detection of micro-RNAs in paraffin samples using LNA probes. Methods 2010;52:375-381.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995;57:289-300.
33. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-688.
34. Baffa R, Fassan M, Volinia S et al. microRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009;219:214-221.
35. Garzon R, Garofalo M, Martelli MP et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008;105:3945-3950.
36. Nakata K, Ohuchida K, Mizumoto K et al. micro-RNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 2011;150:916-922.
37. Sasayama T, Nishihara M, Kondoh T et al. microRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 2009;125:1407-1413.
38. Tian Y, Luo A, Cai Y et al. microRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010;285:7986-7994.
39. Jukic DM, Rao UN, Kelly L et al. microRNA profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med 2010;8:27.
40. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007;67:976-983.
41. Guessous F, Alvarado-Velez M, Marcinkiewicz L et al. Oncogenic effects of miR-10b in glioblastoma stem cells. J Neurooncol 2013;112:153-163.
42. Liang S, Chen L, Huang H et al. The experimental study of miRNA in pituitary adenomas. Turk Neurosurg 2013;23:721-727.
43. Shen Y, Tang D, Yao R et al. microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected nonsmall-cell lung cancer with EGFR mutation. Med Oncol 2013;30:750.